Navigation bar for Vinay Pathak's pages on HIV Drug Resistance Program websiteVinay Pathak's home page on HIV Drug Resistance Program websiteVinay Pathak's research summary on HIV Drug Resistance Program websiteVinay Pathak's publications page on HIV Drug Resistance Program websiteVinay Pathak's staff page on HIV Drug Resistance Program websitePathak lab awards page on HIV Drug Resistance Program website
... Skip navigation links
Link to home page of HIV Drug Resistance Program website
Link to Mission, HIV Drug Resistance Program, National Cancer Institute
Link to News & Events, HIV Drug Resistance Program, National Cancer Institute
Link to Research Team, HIV Drug Resistance Program, National Cancer Institute
Link to Clinical Trials, HIV Drug Resistance Program, National Cancer Institute
Link to Recruitment, HIV Drug Resistance Program, National Cancer Institute
Link to Resources, HIV Drug Resistance Program, National Cancer Institute
Link to Related Sites, HIV Drug Resistance Program, National Cancer Institute
Link to Staff Directory, HIV Drug Resistance Program, National Cancer Institute

Link to National Cancer Institute - external website
Link to National Cancer Institute at Frederick - external website
...

Photo of Vinay Pathak


Head, Viral Mutation Section

HIV Drug Resistance Program
Center for Cancer Research
National Cancer Institute
P.O. Box B, Building 535
Frederick, MD 21702-1201
Phone: 301-846-1710
Fax: 301-846-6013
E-mail: pathakv@mail.nih.gov


Dr. Vinay K. Pathak received his B.A. in Biology from the University of California, Los Angeles, in 1979.  He obtained his M.S. in Comparative Pathology in 1983 from the University of California, Davis, for characterization of mouse mammary tumor virus proviral integration sites near the int1 and int2 loci in mammary tumors and hyperplastic tissues in Dr. Robert Cardiff's laboratory.  He received his Ph.D. for work on characterization of the eukaryotic protein synthesis initiation factors eIF-2
a and eIF-2b in Dr. John W.B. Hershey's laboratory at the University of California, Davis, in 1988.  He was a postdoctoral fellow under the guidance of Dr. Howard Temin from 1988 to 1991, where he determined the in vivo forward mutation rate of spleen necrosis virus and characterized the nature of mutations that arise during retroviral replication.  These studies were the first to report G-to-A hypermutation in a retrovirus, now known to be the result of cytidine deamination by host restriction APOBEC3 proteins.  In 1991, Dr. Pathak became an Assistant Professor in the Department of Biochemistry and the Mary Babb Randolph Cancer Center at West Virginia University.  He was promoted to Associate Professor with tenure in 1998.  He joined the National Cancer Institute in 1999 as Senior Investigator and Head of the Viral Mutation Section in the HIV Drug Resistance Program.  Dr. Pathak was appointed as Guest Editor for the "HIV Drug Resistance" special issue of Viruses, published in 2010.  In 2012, he received the NIH Asian and Pacific Islander American Organization Award for outstanding accomplishments in biomedical research.  He currently serves as a member of the organizing committee of the Annual Norman P. Salzman Symposium in Virology, NIH, and as a member of the Earl Stadtman Virology Search Committee.



Last modified: 21 February 2014

...



HIV DRP Home
Mission | News & Events | Research Team | Clinical Trials | Recruitment | Resources
Related Sites | Staff Directory | NCI Home | NCI at Frederick | Site Map | Disclaimers & Policies | Contact Us

Accessibility | Viewing Files

National Cancer Institute logo     Health and Human Services logo National Institutes of Health logo Logo of USA.gov official web portal